SNN Stock Rises on the Completion of First Case With CATALYSTEM System
Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.
Smith & Nephew (SNN), HOPCo to Enhance Musculoskeletal Care
Smith & Nephew (SNN) announces a collaboration with HOPCo to focus on enhancing solutions for ASC customers, physicians, and patients through the latter's digital health and analytics platforms.
Smith & Nephew shares rise as profit beats market forecast
Smith & Nephew's shares rose 9% on Thursday after the British medical equipment maker's half-year profit beat market forecast, helped by a strong performance in its orthopaedics segment.
Should Value Investors Buy Smith & Nephew SNATS (SNN) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
Smith & Nephew's (SNN) CATALYSTEM System Gets FDA Clearance
Smith & Nephew (SNN) announces the receipt of FDA clearance for its new CATALYSTEM Primary Hip System, which is intended to address the demands of primary hip surgery.
Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins
British company Smith & Nephew is already a global leader in medical tech. Cevian could help it boost its profitability.
Smith & Nephew shares surge as activist Cevian Capital reveals 5% stake
Activist investor Cevian Capital on Thursday revealed it has built up a 5% stake in British medical equipment seller Smith & Nephew, causing shares in the struggling FTSE-100 company to surge.
Smith & Nephew: Work To Be Done But Still Long-Term Potential
Smith & Nephew's share price has increased by 14% since September 2022, indicating undervaluation. The company showed decent top line growth with a 6.4% increase in revenue last year. While the com...
Smith & Nephew plc (SNN) Q1 2024 Sales/Trading Statement Call Transcript
Smith & Nephew plc (NYSE:SNN ) Q1 2024 Sales/Trading Statement Conference Call May 1, 2024 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer John Rogers - Chief Financial Office...
Smith & Nephew tops Footsie after bullish sales update
Smith & Nephew jumped to the top of the FTSE 100 as the UK MedTech delivered a confident first-quarter update and reiterated revenues would grow strongly over the remainder of the year. Sales were ...
Smith+Nephew (SNN) Expands in Australia With New Alliance
The latest partnership allows Smith+Nephew (SNN) to complement its existing implant range with the cutting-edge navigation technology of NAVBIT.
Smith & Nephew: Scepticism has been overplayed, says leading investment bank
JP Morgan has spotlighted Smith & Nephew PLC (LSE:SN) for its revenue acceleration and margin expansion potential, setting a price target of 1,300p - a 21% premium to the current stock price. Despi...
Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript
Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript
Smith & Nephew profits meet targets, 'robust' growth expected in 2024
Smith & Nephew PLC (LSE:SN) kept its dividend unchanged and guided to solid growth this year as it reported 2023 results in line with improved guidance from last summer. The hip and knee replacemen...
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
Related Companies